The Kidney Transplant Market is estimated to be valued at US$ 86139.17 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Kidney transplant involves the surgical removal of diseased kidneys from a person and replacing them with healthy kidneys from another person (the organ donor). Kidney transplant offers better quality and longer length of life than dialysis for patients with kidney failure. It restores kidneys' ability to regulate fluid balance, remove waste from the blood, control blood pressure, make red blood cells, and produce vitamins.
Market key trends:
One of the major trends in the kidney transplant market is technological advancements in transplant procedures. Companies are focusing on developing new surgical tools and techniques to minimize the risk of transplant complications and rejections. For instance, Transonic Systems Inc. offers novel organ perfusion technologies like kidney transporters that enable safe kidney storage and transport for a longer time and improve post-transplant organ function and survival. Similarly, TransMedics Inc. offers organ care systems (OCS) that provide active organ preservation and transportation of donor organs. These technological advancements are expected to boost the market growth over the forecast period.
Porter's Analysis
Threat of new entrants: The barriers to entry in this market are relatively high due to required regulations, high capital investment needs, and established brand loyalty.
Bargaining power of buyers: Individual patients have little bargaining power, but large hospitals and health systems can negotiate lower prices from manufacturers.
Bargaining power of suppliers: A few large suppliers dominate the manufacturing of key immunosuppressant drugs used for anti-rejection, giving them some pricing power.
Threat of new substitutes: No therapies have emerged that can fully replace kidney transplantation, though dialysis remains an alternative treatment option.
Competitive rivalry: Competition is intense among existing players to develop new drugs, devices, and procurement techniques that can gain market share.
SWOT Analysis
Strengths: Established brands, technology leadership positions, and scale advantages for major players.
Weaknesses: High R&D costs, regulatory hurdles, potential side effects of anti-rejection drugs.
Opportunities: Growing prevalence of kidney failure, especially in developing nations. Expanding access through public-private partnerships.
Threats: Cost containment pressures, biosimilars erosion of drug prices over time, and slower market growth in developed countries.
Key Takeaways
The Global Kidney Transplant Market Size is expected to witness high growth, exhibiting CAGR of 3.1% over the forecast period, due to increasing prevalence of chronic kidney diseases. The United States dominates the market currently due to the high volume of kidney transplants performed in the country each year.
Regional analysis: The Asia Pacific region is poised to grow the fastest during the forecast period due to growing incidence of lifestyle diseases such as diabetes in developing countries and increasing investment by both public and private sectors in expanding healthcare access. Countries like India and China are emerging as major transplant hubs.
Key players: Key players operating in the kidney transplant market incorporate Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc. They focus on new drug and device development as well as strategic collaborations to improve outcomes and lower costs.
Read more
https://www.ukwebwire.com/kidney-transplant-market-size-share-growth-outlook-2023/
